Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose_dense Capecitabine Schedule [7days on _7days Off] in Colorectal Cancer in Comparison With Standered Regimen

NCT07215936 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT07215936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07215936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose_dense Capecitabine Schedule [7days on _7days Off] in Colorectal Cancer in Comparison With Standered Regimen
Lead sponsor
Sohag University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
September 25, 2025
Completion date
September 30, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer